Xpert MTB/RIF
|
22.5% *#□$£ (12.4, 37.6) 9/40
|
98% (89.2, 99.7) 47/48
|
90% (59.6, 98.3) 9/10
|
60.3% †◊●▪ (49.2, 70.4) 48/78
|
10.8 (1.43, 81.65)
|
0.79¢°¤§¿ (0.67, 0.94)
|
IFN-γ
|
92.5%*O (80.2, 97.5) 37/40
|
95.9% (86.1, 98.9) 46/48
|
94.9% (83.2, 98.6) 37/39
|
93.9%†∞ (83.5, 97.9) 46/49
|
22.20 (5.70, 86.46)
|
0.08¢ð (0.03, 0.23)
|
ADA (Clinical cut point)
|
79% ∆#× (63.7, 89) 30/38
|
92.7% (80.6, 97.5) 38/41
|
91% (73.4, 95.4) 30/33
|
82.7% ‡◊ (69.3, 91.0) 38/46
|
10.79 (3.59, 32.47)
|
0.23° (0.12, 0.42)
|
ADA (Rule-in cut point)
|
55.3% □O×€¥ (39.8, 69.9) 21/38
|
95.2% (83.9, 98.7) 39/41
|
91.4% (73.3, 97.6) 21/23
|
69 · 7% ∞⌂ (56.7, 80.1) 39/56
|
11.33 (2.85, 45.1)
|
0.47¤ðþ (0.33, 0.67)
|
Xpert MTB/RIF followed by IFN-γ if MTB/RIF-negative
|
92.5%$€ (80.2, 97.5) 37/40
|
93.8% (83.2, 97.9) 45/48
|
92.5% (80.2, 97.5) 37/40
|
93.8%●⌂ (83.2, 97.9) 45/48
|
14.80 (4.93, 44.43)
|
0.08§þ (0.03, 0.24)
|
Xpert MTB/RIF followed by ADA (clinical cut-point) if MTB/RIF-negative
|
81.6%£¥ (66.6, 90.8) 31/38
|
92.7% (80.6, 97.5) 38/41
|
91.2% (77.1, 97) 31/34
|
84.5%▪ (71.3, 92.3) 38/45
|
11.15 (3.70, 33.49)
|
0.20¿ (0.10, 0.39)
|
p-value
|
*; #; $ and £: p < 0.0001 O; □; ×; € and ¥: p < 0.05
| | |
† and ●: P < 0.0001 ◊; ∞; ▪ and ⌂: p < 0.05
| |
¢; °; ¤; §; ¿; ð and þ: non overlapping CI
|